Side-by-side comparison of AI visibility scores, market position, and capabilities
Dallas professional services/infrastructure engineering (NYSE: J) ~$9B revenue; "Challenge Accepted" strategy 6-8% growth FY25-29, water/PFAS remediation ($220B SAM) + semiconductor fab design ($120B SAM) competing with AECOM.
Jacobs Solutions Inc. is a Dallas, Texas-based professional technical services and solutions company — publicly traded on the New York Stock Exchange (NYSE: J) as an S&P 500 Industrials component — providing engineering, design, consulting, operations and maintenance, and advisory services for critical infrastructure, water management, environmental remediation, life sciences facilities, and advanced manufacturing through approximately 45,000 employees in 40+ countries. Formerly known as Jacobs Engineering Group and renamed Jacobs Solutions in 2023, the company has refocused its portfolio around two high-growth end markets after divesting its government IT and cyber services business (Critical Mission Solutions, sold to Amentum in 2024). At its 2025 Investor Day, Jacobs outlined its "Challenge Accepted" strategy targeting 6-8% adjusted net revenue growth from FY2025 through FY2029, concentrating on two large serviceable addressable markets: water and environmental ($220 billion SAM, driven by PFAS remediation, municipal water infrastructure investment, and environmental compliance) and life sciences and advanced manufacturing ($120 billion SAM, driven by pharmaceutical/biotech facility construction and semiconductor fab engineering). The company raised fiscal 2025 adjusted EPS guidance to $6.00-$6.10. CEO Bob Pragada, who succeeded Steve Demetriou in 2023, has accelerated the portfolio transformation toward these higher-margin, higher-growth end markets where technical specialization creates differentiation from generalist engineering firms.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.